Finance

Lists
603998:SHA
Hunan Fangsheng Pharmaceutical Co Ltd
CNÂ¥10.58
+0.38%
(+0.040) 1D
Nov 18, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603998...
Open
CNÂ¥10.57
High
CNÂ¥10.68
Low
CNÂ¥10.44
Mkt. cap
4.63B
Avg. vol.
10.91M
Volume
15.71M
Dividend
4.25%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
Nov 12, 2026
P/E ratio
14.21
52-wk high
CNÂ¥12.88
52-wk low
CNÂ¥8.64
EPS
CNÂ¥0.74
Shares outstanding
418.43M
No. of employees
2K
Open
CNÂ¥10.57
High
CNÂ¥10.68
Low
CNÂ¥10.44
Mkt. cap
4.63B
Avg. vol.
10.91M
Volume
15.71M
Dividend
4.25%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
Nov 12, 2026
P/E ratio
14.21
52-wk high
CNÂ¥12.88
52-wk low
CNÂ¥8.64
EPS
CNÂ¥0.74
Shares outstanding
418.43M
No. of employees
2K
News stories
From web sources and news partners
About Hunan Fangsheng Pharmaceutical Co Ltd
CEO-
Employees1.87K
FoundedOct 13, 1997
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
493.13M
462.77M
494.97M
426.45M
Cost of goods sold
136.60M
114.17M
118.07M
111.85M
Cost of revenue
136.60M
114.17M
118.07M
111.85M
Research and development expenses
46.39M
36.18M
34.54M
27.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
234.51M
200.92M
224.61M
166.36M
Operating expense
306.97M
243.57M
271.28M
199.46M
Total operating expenses
443.57M
357.74M
389.35M
311.31M
Operating income
49.55M
105.03M
105.63M
115.14M
Other non operating income
5.51M
-166.90K
-35.30K
332.01K
EBT including unusual items
54.08M
103.64M
129.69M
107.50M
EBT excluding unusual items
52.08M
103.55M
125.59M
111.49M
Income tax expense
16.79M
15.78M
18.58M
16.34M
Effective tax rate
31.06%
15.22%
14.32%
15.20%
Other operating expenses
18.25M
6.32M
11.25M
2.95M
Net income
38.10M
88.39M
109.27M
91.02M
Net profit margin
7.73%
19.10%
22.08%
21.34%
Earnings per share
-
-
-
-
Interest and investment income
216.57K
1.03M
22.35M
-
Interest expense
-3.12M
-2.34M
-2.34M
-4.00M
Net interest expenses
-2.90M
-1.31M
20.01M
-4.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
68.57M
124.05M
125.11M
134.15M
Gain or loss from assets sale
-51.39M
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps